BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
Rheumatology (Oxford)
.
2017 Dec 1;56(12):2257.
doi: 10.1093/rheumatology/kex389.
Authors
Jo Ledingham
1
,
Nicola Gullick
2
,
Katherine Irving
2
,
Rachel Gorodkin
3
,
Melissa Aris
3
,
Jean Burke
4
,
Patrick Gordon
2
,
Dimitrios Christidis
5
,
Sarah Galloway
6
,
Eranga Hayes
7
,
Andrew Jeffries
8
,
Scott Mercer
9
,
Janice Mooney
10
,
Sander van Leuven
11
,
James Galloway
12
Affiliations
1
Rheumatology Department, Portsmouth NHS Hospitals Trust, Portsmouth.
2
Rheumatology Department, King's College Hospital NHS Foundation Trust, London.
3
Rheumatology Department, Central Manchester University Hospitals NHS Foundation Trust, Manchester.
4
National Rheumatoid Arthritis Society, Maidenhead.
5
Rheumatology Department, Epsom and St Helier University Hospitals NHS Trust, Epsom.
6
South Brent Health Centre, Devon.
7
North Street Medical Practice, Peterborough.
8
Rheumatology Department, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool.
9
Department of Pharmacy, Guy's and St Thomas' Hospital NHS Foundation Trust, London.
10
School of Health Sciences, University of East Anglia, Norwich, UK.
11
Rheumatology Department, Radboud University Medical Centre, Nijmegen, The Netherlands.
12
Rheumatology Department, King's College London, London, UK.
PMID:
29029272
DOI:
10.1093/rheumatology/kex389
No abstract available
Publication types
Published Erratum